Lanean...
A single, clinically relevant dose of the GABA(B) agonist baclofen impairs visuomotor learning
The GABA(B) agonist baclofen is taken daily as a treatment for spasticity by millions of stroke, brain injury and multiple sclerosis patients, many of whom are also undergoing motor rehabilitation. However, decreases in GABA are suggested to be a key feature of human motor learning, which raises que...
Gorde:
| Argitaratua izan da: | J Physiol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7611062/ https://ncbi.nlm.nih.gov/pubmed/33085094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1113/JP280378 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|